It is therefore possible that loss of hepatic FXR and TGR5 signalling in Akr1d1–/– males could increase VLDL synthesis and reduce fatty acid uptake, simultaneously reducing hepatic triacylglycerol levels and contributing to hyperlipidemia. Here, AKR1D1 is linked to hyperlipidemia.